- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Hester Biosciences Limited — Updates, 12-11-2025: Press Release
12-11-2025 | 11:40 am
12-11-2025 | 11:40 am
Hester reports Q2 Standalone sales down 12% to ₹64.5 Cr, PAT down 23%. Consolidated PAT surged 71% to ₹14.3 Cr despite sales decline. Animal healthcare hit by program delays, but H9N2 vaccine authorization opens export growth. Focus on diversification.
No comments yet. Be the first to comment!